{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T18:04:33Z","timestamp":1767117873468,"version":"3.48.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 2024 Yeungnam University Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04647-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:14:07Z","timestamp":1764040447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of catheter outcomes according to dialysis modality and clinical factors in patients with femoral dialysis catheters"],"prefix":"10.1186","volume":"26","author":[{"given":"A-Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Hyang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Young","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Hui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"3","key":"4647_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1774-9987.2005.00258.x","volume":"9","author":"R Ponikvar","year":"2005","unstructured":"Ponikvar R. Hemodialysis catheters. Ther Apher Dial. 2005;9(3):218\u201322.","journal-title":"Ther Apher Dial"},{"issue":"9","key":"4647_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10096-008-0507-5","volume":"27","author":"L Lorente","year":"2008","unstructured":"Lorente L, Jimenez A, Garcia C, et al. Catheter related bactremia from femoral and central internal jugular venous access. Eur J Clin Microbiol Infect Dis. 2008;27(9):867\u201371.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"4647_CR3","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1111\/j.1523-1755.2005.00762.x","volume":"68","author":"ID Maya","year":"2005","unstructured":"Maya ID, Allon M. Outcomes of tunneld femoral Hemodialysis catheters; comparison with internal jugular vein catheters. Kidney Int. 2005;68(6):2886\u20139.","journal-title":"Kidney Int"},{"issue":"7","key":"4647_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/IJNRD.S46643","volume":"8","author":"D Santoro","year":"2014","unstructured":"Santoro D, Bonedetto F, Mondello P, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis. 2014;8(7):281\u201394.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"4647_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.24184\/tip.2022.7.1.8","volume":"7","author":"HI Kim","year":"2022","unstructured":"Kim HI. Internal jugular central venous catheterization: a focus on the procedure. Trauma Image Proced. 2022;7(1):8\u201314.","journal-title":"Trauma Image Proced"},{"issue":"3","key":"4647_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.23736\/S1824-4777.23.01600-5","volume":"30","author":"IG Putra","year":"2023","unstructured":"Putra IG, Soebroto H, Sembiring YE, et al. The longevity of temporary Hemodialysis catheters by insertion site in patients undergoing Hemodialysis: systematic review. Italian J Vascular Endovascular Surg. 2023;30(3):100\u20136. https:\/\/doi.org\/10.23736\/S1824-4777.23.01600-5.","journal-title":"Italian J Vascular Endovascular Surg"},{"issue":"3","key":"4647_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12701\/yujm.2019.00465","volume":"37","author":"SH Kang","year":"2020","unstructured":"Kang SH, Do JY. Improvement of catheter-related outcomes after application of tunneled cuffed Hemodialysis catheter insertion without fluoroscopy. Yeungnam Univ J Med. 2020;37(3):186\u201393.","journal-title":"Yeungnam Univ J Med"},{"key":"4647_CR8","unstructured":"ESRD Registry Committee. Korean Renal Dialysis System (KORDS) 2023 [cited 9 September 2024]. Available from: https:\/\/ksn.or.kr\/bbs\/index.php?code=report"},{"issue":"4","key":"4647_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21315\/mjms2021.28.4.10","volume":"28","author":"R Cheraghali","year":"2021","unstructured":"Cheraghali R, Farshdmehr P. The patency rate of the primary and exchanged femoral haemodialysis catheters. Malays J Med Sci. 2021;28(4):97\u2013102.","journal-title":"Malays J Med Sci"},{"issue":"6","key":"4647_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s00270-011-0316-6","volume":"35","author":"KR Burton","year":"2012","unstructured":"Burton KR, Guo LQ, Tan KT, et al. Patency of femoral tunneled Hemodialysis catheters and factors predictive of patency failure. Cardiovasdc Intervent Radiol. 2012;35(6):1396\u2013402.","journal-title":"Cardiovasdc Intervent Radiol"},{"issue":"2","key":"4647_CR11","doi-asserted-by":"publisher","first-page":"c43","DOI":"10.1159\/000076398","volume":"96","author":"T Hryszko","year":"2004","unstructured":"Hryszko T, Brzosko S, Mazerska M, Malyszko J, Mysliwiec M. Risk factors of nontunneled noncuffed Hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract. 2004;96(2):c43\u20137.","journal-title":"Nephron Clin Pract"},{"key":"4647_CR12","unstructured":"Weir CB, Jan A. BMI classification percentile and cut off points. Statpearls. 2024."},{"key":"4647_CR13","unstructured":"World Health Organization Regional Office for the Western Pacific Region. The Asia-Pacific perspective: redefining obesity and its treatment. Health Commun Australia. 2000. ISBN 0-9577082-1-1. Sydney, Australia."},{"issue":"3","key":"4647_CR14","first-page":"277","volume":"28","author":"T Dai","year":"2016","unstructured":"Dai T, Cao S, Yang X. Comparison of clinical efficacy between continuous renal replacement therapy and intermittent Hemodialysis for the treatment of sepsis-induced acute kidney injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016;28(3):277\u201380.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"11","key":"4647_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00134-023-07211-8","volume":"49","author":"R Wald","year":"2023","unstructured":"Wald R, Gaudry S, da Costa BR, et al. Initiation of continuous renal replacement therapy versus intermittent Hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial. Intensive Care Med. 2023;49(11):1305\u201316.","journal-title":"Intensive Care Med"},{"key":"4647_CR16","doi-asserted-by":"crossref","unstructured":"Gaudry S, Grolleau F, Barbar S, et al. Continuous renal replacement therapy versus intermittent hemodialysis as frst modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care. 2022;26(1):93.","DOI":"10.1186\/s13054-022-03955-9"},{"key":"4647_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2054-3581-1-15","volume":"8","author":"DR Ward","year":"2014","unstructured":"Ward DR, Moist LM, MacRae JM, et al. Risk factors associated with Hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial. Can J Kidney Health Dis. 2014;8:1:15.","journal-title":"Can J Kidney Health Dis"},{"issue":"1","key":"4647_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12882-021-02426-7","volume":"15","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Matsumoto T, Ohmori H, et al. Effect of increased blood flow rate on renal anemia and Hepcidin concentration in Hemodialysis patients. BMC Nephrol. 2021;15(1):221.","journal-title":"BMC Nephrol"},{"key":"4647_CR19","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y, Miki S, Shimada H, et al. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2021;9(9).","DOI":"10.1002\/14651858.CD013330.pub2"},{"issue":"2","key":"4647_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000516146","volume":"51","author":"B Sansom","year":"2022","unstructured":"Sansom B, Sriram S, Presneill J, Bellomo R. Low blood flow continuous Veno-Venous haemodialysis compared with higher blood flow continuous Veno-Venous haemodiafiltration: effect on alarm Rates, filter Life, and azotaemic control. Blood Purif. 2022;51(2):130\u20137.","journal-title":"Blood Purif"},{"issue":"20","key":"4647_CR21","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.299.20.2413","volume":"299","author":"JJ Parienti","year":"2008","unstructured":"Parienti JJ, Thirion M, M\u00e9garbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299(20):2413\u201322.","journal-title":"JAMA"},{"issue":"6","key":"4647_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1053\/j.ajkd.2014.04.022","volume":"64","author":"HR Chua","year":"2014","unstructured":"Chua HR, Schneider AG, Sherry NL, et al. Initial and extended use of femoral versus nonfemoral double-lumen vascular catheters and catheter-related infection during continuous renal replacement therapy. Am J Kidney Dis. 2014;64(6):909\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"1\u20133","key":"4647_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000439581","volume":"41","author":"R Bellomo","year":"2016","unstructured":"Bellomo R, M\u00e5rtensson J, Lo S, et al. Femoral access and delivery of continuous renal replacement therapy dose. Blood Purif. 2016;41(1\u20133):11\u20137.","journal-title":"Blood Purif"},{"key":"4647_CR24","first-page":"40","volume":"4","author":"YH Ng","year":"2017","unstructured":"Ng YH, Ganta K, Davis H, Pankratz VS, Unruh M. Vascular access site for renal replacement therapy in acute kidney injury: A post hoc analysis of the ATN study. Front Med (Lausanne). 2017;4:40.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4647_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13613-021-00843-3","volume":"11","author":"N Benichou","year":"2021","unstructured":"Benichou N, Lebbah S, Hajage D, et al. Vascular access for renal replacement therapy among 459 critically ill patients: a pragmatic analysis of the randomized AKIKI trial. Ann Intensive Care. 2021;11(1):56.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4647_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.ajkd.2012.08.031","volume":"61","author":"SC Palmer","year":"2013","unstructured":"Palmer SC, Di Micco L, Razavian M, et al. Antiplatelet therapy to prevent Hemodialysis vascular access failure: systematic review and meta-analysis. Am J Kidney Dis. 2013;61(1):112\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"4647_CR27","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1093\/ndt\/gft406","volume":"28","author":"AY Wang","year":"2013","unstructured":"Wang AY, Ivany JN, Perkovic V, Gallagher MP, Jardine MJ. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transpl. 2013;28(11):2875\u201388.","journal-title":"Nephrol Dial Transpl"},{"key":"4647_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12882-023-03383-z","volume":"10","author":"L Lim","year":"2023","unstructured":"Lim L, Park JY, Lee H, et al. Risk factors of Hemodialysis catheter dysfunction in patients undergoing continuous renal replacement therapy: a retrospective study. BMC Nephrol. 2023;10:24:334.","journal-title":"BMC Nephrol"},{"issue":"10","key":"4647_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/039139880402701006","volume":"27","author":"RT Naumovic","year":"2004","unstructured":"Naumovic RT, Jovanovic DB, Djukanovic LJ. Temporary vascular catheters for hemodialysis: a 3-year prospective study. Int J Artif Organs. 2004;27(10):848\u201354.","journal-title":"Int J Artif Organs"},{"issue":"1","key":"4647_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000210034","volume":"28","author":"X Lemaire","year":"2009","unstructured":"Lemaire X, Morena M, Leray-Moragu\u00e9s H, Henriet-Viprey D, Chenine L, Defez-Fougeron C, Canaud B. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for Hemodialysis. Blood Purif. 2009;28(1):21\u20138.","journal-title":"Blood Purif"},{"issue":"3","key":"4647_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bjh.14885","volume":"179","author":"X Li","year":"2017","unstructured":"Li X, Ma X. The role of heparin in sepsis: much more than just an anticoagulant. Br J Haematol. Nov; 2017;179(3):389\u201398.","journal-title":"Br J Haematol"},{"issue":"4","key":"4647_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/1744-9987.12776","volume":"23","author":"T Sahutoglu","year":"2019","unstructured":"Sahutoglu T, Erinc O, Avsar FN, et al. Which type of temporary Hemodialysis catheter should be used for the right internal jugular vein? Prospective observational study of straight vs. Precurved catheters. Ther Apher Dial. 2019;23(4):328\u201335.","journal-title":"Ther Apher Dial"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04647-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T18:02:07Z","timestamp":1767117727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04647-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4647"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04647-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Yeungnam University Hospital (2024-08-012). The requirement of informed consent was waived, as patients\u2019 records and information were anonymized and de-identified before analysis. The study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. This study is not a clinical trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"713"}}